COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes: A Secondary Analysis of a Randomized Clinical Trial

Henrique Andrade R Fonseca; Lucas Petri Damiani; Frederico Monfardini; André Zimerman; Luiz Vicente Rizzo; Otávio Berwanger

doi:10.1001/jamanetworkopen.2024.13946

COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes: A Secondary Analysis of a Randomized Clinical Trial

JAMA Netw Open. 2024 May 1;7(5):e2413946. doi: 10.1001/jamanetworkopen.2024.13946.

Authors

Henrique Andrade R Fonseca¹, Lucas Petri Damiani¹, Frederico Monfardini¹, André Zimerman², Luiz Vicente Rizzo¹, Otávio Berwanger^{1

3}

Affiliations

¹ Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, São Paulo, Brazil.
² Thrombolysis in Myocardial Infarction Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ George Institute for Global Health UK at Imperial College, London, United Kingdom.

No abstract available

Plain language summary

This secondary analysis of a randomized clinical trial investigates the association of COVID-19 vaccination with incidence of cardiopulmonary events among patients who had experienced acute coronary syndromes.

Publication types

Randomized Controlled Trial

MeSH terms

Acute Coronary Syndrome*
Aged
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Female
Humans
Male
Middle Aged
SARS-CoV-2*
Vaccination / adverse effects

Substances

COVID-19 Vaccines